Enanta Pharmaceuticals Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.10%
vs ±19.1% implied · ×0.11
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $53.3M | 13.37% | — | |
| 2 | BlackRockBlackRockindex-like | $47.3M | 11.88% | +4.53% | |
| 3 | Krensavage Asset ManagementKrensavage | $41.8M | 10.49% | 0.00% | |
| 4 | Farallon Capital ManagementFarallon | $35.3M | 8.85% | new | |
| 5 | Deep Track CapitalDeep Track Capital | $21.1M | 5.29% | −26.20% | |
| 6 | ADAR1 Capital ManagementADAR1 | $19.6M | 4.92% | +2517.97% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $17.7M | 4.44% | +2.86% | |
| 8 | Spruce Street CapitalSpruce Street Capital | $15.9M | 3.99% | +16.74% | |
| 9 | Acadian Asset ManagementAcadian | $15.7M | 3.95% | +22.53% | |
| 10 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $14.7M | 3.70% | +6.60% | |
| 11 | Geode Capital ManagementGeodeindex-like | $11.3M | 2.84% | +7.11% | |
| 12 | Millennium ManagementMillennium | $9.4M | 2.36% | −27.00% | |
| 13 | State StreetState Streetindex-like | $8.4M | 2.11% | +2.49% | |
| 14 | Renaissance TechnologiesRenaissance Technologies | $8.1M | 2.04% | −16.18% | |
| 15 | Hillsdale Investment ManagementHillsdale | $6.8M | 1.71% | +7.46% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $6.8M | 1.70% | +75.28% | |
| 17 | Morgan StanleyMorgan Stanley | $4.6M | 1.16% | +2.01% | |
| 18 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.4M | 1.10% | +2.10% | |
| 19 | Dimensional Fund AdvisorsDimensional | $4.1M | 1.04% | +39.08% | |
| 20 | Northern TrustNorthern Trustindex-like | $3.8M | 0.95% | +7.77% | |
| 21 | SummitTX CapitalSummitTX Capital | $3.8M | 0.94% | new | |
| 22 | AQR Capital ManagementAQR | $3.7M | 0.94% | −17.97% | |
| 23 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.7M | 0.68% | new | |
| 24 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $2.2M | 0.56% | +21.67% | |
| 25 | Rockefeller Capital ManagementRockefeller | $2.2M | 0.55% | +5773.82% |
121 managers report $398.2M of Enanta Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Jupiter Topco is largest at 13.37%.
Linked news
Enanta Pharmaceuticals Inc
10.78
−0.37 · −3.33%
post 10.78 0.00%
Expected move
Inputsspot 10.71exp Nov 20ATM strike 10ATM straddle 2.23IV 108%